CALCA and migraine disorder: Improvement of a symptom or comorbid condition with anti-CGRP-mAbs was reported for migraine aura [124], cluster headache [134,148], headache related to sexual activity [139], nummular headache [160], restless leg syndrome [159], sleep terrors [149], and stuttering [150].